Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
Location: United States, California, San Francisco
Member count: 501-1000
Total raised: $150M
Founded date: 1990
Investors 1
| Date | Name | Website |
| 07.08.2021 | New Enterp... | nea.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.12.2020 | - | $150M | - | prnewswire... |
Mentions in press and media 22
| Date | Title | Description | Category | Author | Source |
| 26.04.2022 | Nektar The... | The biotech Nektar Therapeutic... | - | - | barrons.co... |
| 18.04.2022 | Nektar The... | Shares of the biotech Nektar T... | - | - | barrons.co... |
| 04.11.2021 | Nektar The... | Nektar Therapeutics Reports Th... | - | - | marketscre... |
| 20.05.2021 | Nektar The... | SAN FRANCISCO, May 20, 2021 ... | - | - | prnewswire... |
| 18.05.2021 | Nektar The... | SAN FRANCISCO, May 18, 2021 ... | - | - | prnewswire... |
| 17.02.2021 | Nektar Ann... | SAN FRANCISCO, Feb. 17, 2021... | - | - | prnewswire... |
| 17.02.2021 | Nektar Ann... | SAN FRANCISCO, Feb. 17, 2021... | - | - | prnewswire... |
| 22.12.2020 | Nektar The... | SAN FRANCISCO, Dec. 22, 2020 /... | - | - | marketscre... |
| 22.12.2020 | Nektar The... | SAN FRANCISCO, Dec. 22, 2020... | - | - | prnewswire... |
| 22.12.2020 | NEKTAR THE... | SAN FRANCISCO, Dec. 22, 2020 /... | - | - | marketscre... |
Show more